Perioperative optimization of nutrition leads to lower risks, better outcomes, and improved quality of life for patients.

A retrospective population-based study showed that severe obesity and bariatric surgery independently increased the risk of inflammatory bowel disease.

Administration of semaglutide before metabolic and bariatric surgery does not confer benefits for overall weight loss, ...

A study by Mass General Brigham found that taking the weight-loss drug semaglutide before bariatric surgery does not lead to ...

Actress-comedienne Enot recently dismissed the idea that she had undergone bariatric surgery to achieve her current look, ...

A RETROSPECTIVE study conducted by Mass General Brigham researchers has found that taking semaglutide before bariatric ...

Struggling to lose weight and concerned about serious health complications? For long-lasting success, consider Ochsner Health ...

Neoadjuvant semaglutide before metabolic and bariatric surgery (MBS) is not beneficial in terms of weight loss, according to a research letter published online March 5 in JAMA Surgery. Vasundhara ...

A new study finds that ursodeoxycholic acid (UDCA) effectively dissolves gallstones in 60% of patients after sleeve ...

GT Metabolic™ Solutions, Inc., the world leader in magnetic surgery is pleased to announce that the U.S. Food and Drug ...

We applied the novel Predicting Risk of Cardiovascular Disease EVENTs equations to evaluate cardiovascular–kidney–metabolic (CKM) health and estimated cardiovascular disease (CVD) risk after bariatric ...